Stock detail
Repligen (RGEN) stock price, chart, and key data
View Repligen stock price, chart movement, and headline metrics on Woodstock's stock detail page.
Stock detail
Repligen
RGEN · XNAS
$165.76
+0.66%
+$1.08
Key metrics
52-week range
$9.75 - $5.00
Close price
$164.68
Market cap
$9.3B
P/E ratio
225.59
Beta
0.68
About the company
Repligen Corp
Repligen Corporation is an American life sciences company that develops and manufactures products used in biological drug manufacturing. The company is headquartered in Waltham, Massachusetts, and is listed on the Nasdaq under the symbol RGEN.
Analyst rating summary
A current read on analyst sentiment from the insight feed.
Mean target
$184
11
Buy
/ 12
Recent calls
09/09/2026
UBS
Unknown Analyst
Buy · Price target $225
08/16/2026
Wells Fargo
Evan Stampler
Buy · Price target $185
07/30/2026
Wells Fargo
Brandon Couillard
Buy · Price target $185
Ticker holders
Review politician disclosures and insider transactions in tabs.
Holder directory
Select a heading to reorder by name, activity date, buy/sell, or displayed value.
#1Jefferson Shreve republican · House · IN-6 self |
| $15,001/$32,501/$50,000 |
#2Lisa McClain republican · House · MI-9 spouse |
| 2/16/30 |
#3Donald J Trump republican · Executive self |
| 1/3/7 |
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app